We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Chromogenic Screening Medium Developed for MRSA

By LabMedica International staff writers
Posted on 13 Aug 2014
A novel chromogenic screening agar medium for methicillin-resistant Staphylococcus aureus (MRSA) has been developed, as rapid and definite detection of MRSA is important not only diagnosis but also for preventing the spread of this bacteria.

MRSA is known as a major nosocomial pathogen, which causes a variety of clinical symptoms including septicemia, pneumonia, and postsurgical toxic shock syndrome and treatment of infections by MRSA has been problematic since MRSA is resistant to many antimicrobial agents.

Scientists at the Kohjin Bio Co., Ltd. More...
(Saitama, Japan) compared the company’s MRSA-chrom media with other commercially available media to detect MRSA. Forty-two strains of MRSA including 41 clinical isolates from nasal cavity were inoculated into the media for the inclusivity study. For the exclusivity study, 52 gram-positive strains other than MRSA, 36 gram-negative strains, and 3 yeasts were inoculated into suitable culture media.

A total of 42 MRSA strains grew and formed typical blue- and mauve-colored colonies on MRSA-chrom and CHROMagar MRSA (CHROMagar Microbiology; Paris, France) in 24 hours. Of 42 MRSA strains, 37 strains grew and formed typical yellow colonies with egg yolk turbid reaction for S. aureus on three other media in 48 hours. All of the other microbes tested including 17 methicillin-sensitive S. aureus (MSSA) strains failed to grow on MRSA-chrom. The colonies of Bacillus cereus were spread and had a frosted glass appearance and as a result, these colonies could be distinguished from MRSA easily. When the scientists tested the 50 clinical specimens, they found that both chromogenic media detected MRSA as typical colored colony from 33 specimens after 24 hours of incubation.

The authors concluded that the novel chromogenic medium, MRSA-chrom, developed for the screening of MRSA was excellent for both selectivity and detectability. Therefore, they suggested that MRSA-chrom was a useful alternative for rapid and definitely screening of MRSA. Moreover, MRSA-chrom had a good growth for MRSA since it contained no sodium chloride. The study was published in the August 2014 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Kohjin Bio Co., Ltd.
CHROMagar Microbiology



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
Hepatitis A Rapid Test
Anti-HAV IgM Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: This image shows a second-generation version of the device that can also measure cell morphology (Photo courtesy of MIT)

Rapid Cell Density Measurement Technique to Help Predict Immunotherapy Response

The density of a cell provides valuable insights into its condition. As cells go through processes such as proliferation, differentiation, or cell death, they may gain or lose water and other molecules,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.